A novel wastewater-based epidemiology indexing method predicts SARS-CoV-2 disease prevalence across treatment facilities in metropolitan and regional populations


Posted: 2021-11-02 19:00:00
There is a need for wastewater based epidemiological (WBE) methods that integrate multiple, variously sized surveillance sites across geographic areas. We developed a novel indexing method, Melvin's Index, that provides a normalized and standardized metric of wastewater pathogen load for qPCR assays that is resilient to surveillance site variation. To demonstrate the utility of Melvin's Index, we used qRT-PCR to measure SARS-CoV-2 genomic RNA levels in influent wastewater from 19 municipal wastewater treatment facilities (WWTF's) of varying sizes and served populations across the state of Minnesota during the Summer of 2020. SARS-CoV-2 RNA was detected at each WWTF during the 20-week sampling period at a mean concentration of 8.5 × 104 genome copies/L (range 3.2 × 102-1.2 × 109 genome copies/L). Lag analysis of trends in Melvin's Index values and clinical COVID-19 cases showed that increases in indexed wastewater SARS-CoV-2 levels precede new clinical cases by 15-17 days at the statewide level and by up to 25 days at the regional/county level. Melvin's Index is a reliable WBE method and can be applied to both WWTFs that serve a wide range of population sizes and to large regions that are served by multiple WWTFs.

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
5月 08, 2020 バイオアソシエイツ

CytoDyn社、COVID-19薬のレロンリマブについて更新。 初期の結果は、Gilead社のレムデシビルに対する明確な優位性を示唆。(プレゼン全容)

レロンリマブ要約:- COVID-19 の三拍子揃った薬-レロンリマブはサイトカインストームを静め、免疫学的ホメオスタシスを回復し、ウイルス量を減らす-Gileadの抗ウイルス薬レムデシビルとGenetechの抗IL-6…

ゲスト 578人 と メンバー 2人 がオンラインです